BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice

Author(s):
Dam, A.D. van; Bekkering, S.; Crasborn, M.; Beek, L. van; Berg, S.M. van den; Vrieling, F.; Joosten, S.A. (0000-0002-9878-0863); Harmelen, V. van; Winther, M.P.J. de; Lutjohann, D.; Lutgens, E.; Boon, M.R.; Riksen, N.P.; Rensen, P.C.N. (0000-0002-8455-4988); Berbee, J.F.P.
Published
2016
Publication type
Article / Letter to editor

Abstract

Conclusions: BCG reduces plasma nonHDL-cholesterol levels and delays atherosclerotic lesion formation in hyperlipidemic mice. (C) 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

AtherosclerosisBCGHepatitisHypercholesterolemia
Date issued
2016-08-01
Language
English
Publisher
ELSEVIER IRELAND LTD
Is part of
Atherosclerosis (2016), Vol. 251, p. 6-14
hdl
1887/99409
doi
10.1016/j.atherosclerosis.2016.05.031